-
1 Comment
ClearPoint Neuro, Inc is currently in a long term uptrend where the price is trading 8.1% above its 200 day moving average.
From a valuation standpoint, the stock is 97.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 27.8.
ClearPoint Neuro, Inc's total revenue rose by 15.8% to $4M since the same quarter in the previous year.
Its net income has increased by 3.9% to $-2M since the same quarter in the previous year.
Finally, its free cash flow fell by 290.2% to $-2M since the same quarter in the previous year.
Based on the above factors, ClearPoint Neuro, Inc gets an overall score of 4/5.
Exchange | NASDAQ |
---|---|
Sector | Healthcare |
Industry | Medical Devices |
CurrencyCode | USD |
ISIN | US18507C1036 |
Market Cap | 371M |
---|---|
PE Ratio | None |
Target Price | 25 |
Beta | 0.98 |
Dividend Yield | None |
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CLPT using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025